Drugs in R & D

, Volume 3, Issue 1, pp 61–64 | Cite as


A 16686, a 16686a, MDL 62198
Adis R&D Profile


Vancomycin Teicoplanin Pseudomembranous Colitis Nasal Carriage High Fibre Diet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Patoia L, Berchicci P. Ramoplanin. Drugs of the Future. 15: 689–694, Jul 1990. Italy. [English]Google Scholar
  2. 2.
    Romeo B, Kaschube M, Cavenaghi L, Borgonovi M, Jaulhac B, et al. Repeated doses of ramoplanin orally administered to healthy male volunteers: tolerability, lack of absorption and effect on the stool microflora. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy.: 200, 1993. Italy. [English]Google Scholar
  3. 3.
    Bertazzoni Minelli E, Benini A, Muner A, et al. Ramoplanin and human intestinal contents: in vitro interactions. 9th Mediterranean Congress of Chemotherapy.: 90, 1994. Italy. [English]Google Scholar
  4. 4.
    Landman D, Quale JM, Burney S, Kreiswirth B, Willey BM. Treatment of experimental endocarditis caused by multidrug resistant Enterococcus faecium with ramoplanin and penicillin. Journal of Antimicrobial Chemotherapy. 37: 323–329, Feb 1996. USA. [English]PubMedCrossRefGoogle Scholar
  5. 5.
    Lawrence T, Rotstein C, Beam Jr TR, Gorzynski EA, Amsterdam D. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of Gram-positive cocci. Antimicrobial Agents and Chemotherapy. 37: 896–900, Apr 1993. USA. [English]PubMedCrossRefGoogle Scholar
  6. 6.
    Johnson CC, Taylor S, Pitsakis P, May P, Levison ME. Bactericidal activity of ramoplanin against antibiotic-resistant enterococci. Antimicrobial Agents and Chemotherapy. 36: 2342–2345, Oct 1992. USA. [English]PubMedCrossRefGoogle Scholar
  7. 7.
    Mobarakai N, Quale JM, Landman D. Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 38: 385–387, Feb 1994 USA. [English]PubMedCrossRefGoogle Scholar
  8. 8.
    Collins LA, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering Jr RC. In vitro activity of ramoplanin against vancomycin-resistant Gram-positive organisms. Antimicrobial Agents and Chemotherapy. 37: 1364–1366, Jun 1993. USA. [English]PubMedCrossRefGoogle Scholar
  9. 9.
    Wong MT, Porter SB, Kauffman CA, Standiford HC, Fuchs HJ, et al. Clinical efficacy and safety phase II trial of the novel glycolipodepsipeptide, ramoplanin, in the colonic decontamination of patients colonized with VRE. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy: late breaker abstracts.: 16, 26 Sep 1999. USA. [English]Google Scholar
  10. 10.
    Ramoplanin. Clinical Investigator News. 7: 21, Aug 1999. USA. [English]Google Scholar

Copyright information

© Adis International Limited 2002

Personalised recommendations